Trial · NCT02929329
Results by group12
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 12 of 12
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Time to Cardiovascular Death or First Heart Failure Event | Placebo | 39.1 | percentage of participants | ||
| Time to Cardiovascular Death or First Heart Failure Event | Omecamtiv Mecarbil | 37.0 | percentage of participants | ||
| Time to Cardiovascular Death | Placebo | 19.4 | percentage of participants | ||
| Time to Cardiovascular Death | Omecamtiv Mecarbil | 19.6 | percentage of participants | ||
| Change From Baseline in Kansas City Cardiomyopathy Questionnaire Total Symptom Score (KCCQ TSS) at Week 24 | Placebo: Oupatients | 6.29 | Standard Error 0.34 | scores on a scale | |
| Change From Baseline in Kansas City Cardiomyopathy Questionnaire Total Symptom Score (KCCQ TSS) at Week 24 | Omecamtiv Mecarbil: Outpatients | 5.83 | Standard Error 0.34 | scores on a scale | |
| Change From Baseline in Kansas City Cardiomyopathy Questionnaire Total Symptom Score (KCCQ TSS) at Week 24 | Placebo: Inpatients | 21.15 | Standard Error 0.71 | scores on a scale | |
| Change From Baseline in Kansas City Cardiomyopathy Questionnaire Total Symptom Score (KCCQ TSS) at Week 24 | Omecamtiv Mecarbil: Inpatients | 23.65 | Standard Error 0.70 | scores on a scale | |
| Time to First Heart Failure Hospitalization | Placebo | 28.7 | percentage of participants | ||
| Time to First Heart Failure Hospitalization | Omecamtiv Mecarbil | 27.7 | percentage of participants | ||
| Time to All-cause Death | Placebo | 25.9 | percentage of participants | ||
| Time to All-cause Death | Omecamtiv Mecarbil | 25.9 | percentage of participants |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02929329/results